. (OTCQX: LXRP, CSE: LXX), the drug delivery platform firm, has created four wholly-owned subsidiary companies.
Each of the firms has a new website currently under construction and is also clearly branded as part of the Lexaria group of companies.
Lexaria has developed its patented DehydraTECHTM technology.
This provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules.
These include cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules.
Subsidiary Lexaria CanPharm Corp is a Canadian company focused on providing DehydraTECH technology and other enhancements to the global cannabis industry.
Lexaria Nicotine Corp is a US company with a global license to provide DehydraTECH technology to the global nicotine and tobacco industries.
Lexaria Hemp Corp is a US company globally licensed to provide DehydraTECH to the rapidly growing hemp-based foods and supplements industries.
Notably, the firm will soon announce the creation of a new wholly-owned brand that will be introducing a new category-killer product at the upcoming MJBiz conference in Las Vegas on November 14 to 16, 2018.
Elsewhere, Lexaria Pharmaceutical Corp is a US company globally empowered to license DehydraTECH to the large and diverse pharmaceutical sectors, including pain relief, vitamins, PDE5 inhibitors, hormone treatments, central nervous system conditions, and more.
Lexaria will also use its wholly-owned Poviva Tea Corp to advance the existing ViPova Tea and Coffee consumer brands.
